ERBC
ERBC is a leading independent preclinical Contract Research Organization (CRO) in Europe, specializing in non-clinical studies from proof-of-concept to market, supporting industries such as pharmaceutical, biotech, chemical, food, veterinarian, and medical. The company is committed to high-quality, regulatory-compliant research services, animal welfare, innovation, and sustainability, with a strong focus on advancing health and safety through cutting-edge methodologies and ethical practices.
Industries
Nr. of Employees
medium (51-250)
Products
Avian embryo PDX (rapid patient-derived tumor model)
Avian embryo–based patient-derived xenograft model that generates miniaturized, patient-representative tumors for rapid therapeutic evaluation and comparison with standard-of-care within short timeframes.
In vivo multimodal imaging service (optical and tomographic)
Service combining bioluminescence, fluorescence tomography and CT/μ-CT imaging for longitudinal monitoring of disease progression, biodistribution and device performance.
Preclinical microbiology and molecular diagnostics service
Microbiology amplification, PFU/CFU assays, automated colony counting and RT‑qPCR workflows for infectious disease and vaccine testing in BSL‑2/3 settings.
Avian embryo PDX (rapid patient-derived tumor model)
Avian embryo–based patient-derived xenograft model that generates miniaturized, patient-representative tumors for rapid therapeutic evaluation and comparison with standard-of-care within short timeframes.
In vivo multimodal imaging service (optical and tomographic)
Service combining bioluminescence, fluorescence tomography and CT/μ-CT imaging for longitudinal monitoring of disease progression, biodistribution and device performance.
Preclinical microbiology and molecular diagnostics service
Microbiology amplification, PFU/CFU assays, automated colony counting and RT‑qPCR workflows for infectious disease and vaccine testing in BSL‑2/3 settings.
Services
Preclinical proof-of-concept, efficacy, tolerability, ADME/PK/PD and biodistribution studies using in vivo models, PDX and tumor models, and integrated imaging readouts.
Full range of regulatory and investigative toxicology studies (GLP and non-GLP) across species, safety pharmacology core battery and follow-up studies, DART/juvenile programs and regulatory study execution.
Execution of safety pharmacology studies, including core battery assays and specialized cardiovascular monitoring with non-invasive telemetry to assess potential safety risks.
Central laboratory services including biomarker assays, immunology (flow cytometry), analytical chemistry, microbiology assays and bioanalysis to support preclinical and clinical programs.
GCP-compliant clinical pathology and bioanalysis for clinical trial sample processing and data generation.
Breeding, quarantine, housing and supply of non-human primates to support translational and toxicology studies.
Preclinical proof-of-concept, efficacy, tolerability, ADME/PK/PD and biodistribution studies using in vivo models, PDX and tumor models, and integrated imaging readouts.
Full range of regulatory and investigative toxicology studies (GLP and non-GLP) across species, safety pharmacology core battery and follow-up studies, DART/juvenile programs and regulatory study execution.
Execution of safety pharmacology studies, including core battery assays and specialized cardiovascular monitoring with non-invasive telemetry to assess potential safety risks.
Central laboratory services including biomarker assays, immunology (flow cytometry), analytical chemistry, microbiology assays and bioanalysis to support preclinical and clinical programs.
GCP-compliant clinical pathology and bioanalysis for clinical trial sample processing and data generation.
Breeding, quarantine, housing and supply of non-human primates to support translational and toxicology studies.
Expertise Areas
- Preclinical toxicology and safety assessment
- Safety pharmacology
- Oncology models and PDX development
- Infectious disease modeling (BSL-2/BSL-3)
Key Technologies
- In vivo fluorescence imaging
- Bioluminescence imaging
- CT and micro-CT (μ-CT)
- 3D light-sheet imaging
News & Updates
ERBC's Baugy site has renewed its GLP accreditation.
The ERBC Dommartin site has achieved AAALAC accreditation, underscoring its commitment to animal welfare.
Introduction of new digital pathology services at ERBC.
ERBC promotes gender equality and diversity.
Participation in the Oncostart Summit in Paris.
Participation in the BIO International Convention in Boston.
ERBC's Baugy site has renewed its GLP accreditation.
The ERBC Dommartin site has achieved AAALAC accreditation, underscoring its commitment to animal welfare.
Introduction of new digital pathology services at ERBC.
ERBC promotes gender equality and diversity.
Participation in the Oncostart Summit in Paris.
Participation in the BIO International Convention in Boston.